Paul Quintaro - Benzinga

Articles by Paul Quintaro

China Internet Nationwide Financial's Special Committee Responds to Muddy Waters

China Internet Nationwide Financial's Special Committee Responds to Muddy Waters

Domino's Shares Remain Up 3+% For Session Following Circulation Of Report From Mon. Suggesting Burger King Is Considering An Offer For The Co.

Domino's Shares Remain Up 3+% For Session Following Circulation Of Report From Mon. Suggesting Burger King Is Considering An Offer For The Co.

Myomo Issues November 2017 Shareholder Letter

Myomo Issues November 2017 Shareholder Letter

16 Stocks Moving In Monday's After-Hours Session

16 Stocks Moving In Monday's After-Hours Session

Ubiquiti Shares Down 0.4% 1 Day After New Citron Short Report; Co. Announced In 8-K This Morning Addition Of $100M To Buyback Plan, Guidance

Ubiquiti Shares Down 0.4% 1 Day After New Citron Short Report; Co. Announced In 8-K This Morning Addition Of $100M To Buyback Plan, Guidance

Stocks React Lower Following Report North Korea Fired Unidentified Missile From Pyongyang

Stocks React Lower Following Report North Korea Fired Unidentified Missile From Pyongyang

Traders Circulating Techcrunch Article 'LG Display will add $7B to its OLED investment in an attempt to challenge Samsung'

Traders Circulating Techcrunch Article 'LG Display will add $7B to its OLED investment in an attempt to challenge Samsung'

Tesla Outlines The Main Issue Affecting Q2 Deliveries

Tesla Outlines The Main Issue Affecting Q2 Deliveries

Traders Circulating Recent AppleInsider Article 'Apple's 10th anniversary 'iPhone X' could cost more than $1,000 - report'

Traders Circulating Recent AppleInsider Article 'Apple's 10th anniversary 'iPhone X' could cost more than $1,000 - report'

Elliott Mgmt's Full Letter to Cognizant Board

Elliott Mgmt's Full Letter to Cognizant Board

S&P Futures Move More Than Index Record

S&P Futures Move More Than Index Record

Goldman Sachs Downgrades B/E Aerospace, Inc. - Common Stock to Neutral, Lowers Price Target to $52.00

Goldman Sachs Downgrades B/E Aerospace, Inc. - Common Stock to Neutral, Lowers Price Target to $52.00

Emergent Biosolutions Shares Up 13% on Heavy Volume; Co. Earlier Offered Update on Status of BioThrax Procurement contract, Discussions with CDC

Emergent Biosolutions Shares Up 13% on Heavy Volume; Co. Earlier Offered Update on Status of BioThrax Procurement contract, Discussions with CDC

Daxor Corp. Reports Presentation of Two New Studies at Heart Failure Society of America Meeting

Daxor Corp. Reports Presentation of Two New Studies at Heart Failure Society of America Meeting

Alnylam Presents Clinical and Non-Clinical Data Demonstrating Continued RNAi Platform Optimization and Leadership in the Development of RNA-Based Therapeutics at 12th Annual Meeting of the Oligonucleotide Therapeutics Society

Alnylam Presents Clinical and Non-Clinical Data Demonstrating Continued RNAi Platform Optimization and Leadership in the Development of RNA-Based Therapeutics at 12th Annual Meeting of the Oligonucleotide Therapeutics Society

UPDATE: Pfizer Says 2 Divisions Will Remain Separately Managed Within Single Company

UPDATE: Pfizer Says 2 Divisions Will Remain Separately Managed Within Single Company

Pier 1 Response to Alden Global Capital 13D

Pier 1 Response to Alden Global Capital 13D

Versartis Reports Data from Up to 30 Mos. of Somavaratan Treatment for Pediatric Growth Hormone Deficiency

Versartis Reports Data from Up to 30 Mos. of Somavaratan Treatment for Pediatric Growth Hormone Deficiency

UPDATE: Wells Fargo Full Statement on Deals Related to Sales Practices

UPDATE: Wells Fargo Full Statement on Deals Related to Sales Practices

MabVax Therapeutics Sends Letter to Holders Following Uplisting to NASDAQ

MabVax Therapeutics Sends Letter to Holders Following Uplisting to NASDAQ